0 results available. Select is focused ,type to refine list, press Down to open the menu,
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The ...
We've identified the following companies as similar to Vaccinex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Buyback Yield in the valuation category include:
A ratio that measures the difference between the amount of share repurchases and the amount of share issuances over the trailing twelve months divided...
Buyback Yield is defined as:
Share Repurchases - Share Issuances
(/) Market Cap
(=) Buyback Yield
Buyback yield measures the difference between the amount of share repurchases and the amount of share issuances over the trailing twelve months divided by the company’s market capitalization
Read more about shareholder yield, net payout yield, and debt paydown yield
The chart above depicts the distribution of buyback yield for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,359 had meaningful values. The average buyback yield of companies in the sector is -22.0% with a standard deviation of 56.1%.
Vaccinex Inc's Buyback Yield of -602.1% is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,457 |
| Included Constituents | 2,359 |
| Min | -510.3% |
| Max | 6.5% |
| Median | -0.3% |
| Mean | -22.0% |
| Standard Deviation | 56.1% |
You can find companies with similar buyback yield using this stock screener.